Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Diagnosing Goya: Unraveling Medical Mysteries of the Past

By Apr 28, 2017

A doctor has looked back at famous Spainish painter Francisco Goya and the mysterious illness that left him deaf and narrowed her diagnosis down to two possibilities

Bone Building Drug Gets FDA Approval for Osteoporosis

By Apr 28, 2017

Abaloparatide is a parathyroid hormone related peptide [PTHrP(1-34)] analog which acts as an agonist at the PTH1 receptor (PTH1R). This results in activation of the cAMP signaling pathway in target cells.

FDA Approves Brineura for Rare, Fatal Neurodegenerative Disease

By Apr 27, 2017

Results from the analysis showed the odds of Brineura-treated patients not having a decline were 13 times the odds of natural history cohort patients not having a decline (odds ratio 13.1, 95% CI: 1.2, 146.9).

CDC Issues Shigella Management Recommendations

By Apr 21, 2017

The CDC has identified an increase in Shigella isolates with minimum inhibitory concentration (MIC) values of 0.12-1μg/mL for the fluoroquinolone antibiotic ciprofloxacin.

FDA Issues Multiple Restrictions on Codeine, Tramadol Use

By Apr 20, 2017

This new action further limits the use of these medications beyond the 2013 restriction.

More Articles by Diana Ernst, RPh